(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DRUG DIFFERENTIATION BY DESIGN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DRUG DIFFERENTIATION BY DESIGN

ST13

US500000087269501

Class

42

Filing

87269501

Registration

6169614

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

54

Latest update

10/07/2025

Trademark type

Word

Nice classes

42

Filing date

12/15/2016

Registration date

10/06/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/06/2020

Last transaction

10/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/13/2020

First use in commerce

08/13/2020

Drawing code

4

Owner type

03

Owner location

Warren, NJ

Examiner

SETTLES LEWIS,SHAILA E

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AQUESTIVE THERAPEUTICS, INC.
AQUESTIVE THERAPEUTICS, INC.
MonoSol RX, LLC

Representatives

Carrie Webb Olson DAY PITNEY LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticalsmedicinetherapeutics; Consulting services in the fields of pharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

54 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/06/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/26/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/26/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/26/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/25/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

08/25/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/25/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/25/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/06/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/03/2020

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/02/2020

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/25/2020

IUAF

USE AMENDMENT FILED

08/14/2020

EISU

TEAS STATEMENT OF USE RECEIVED

08/14/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/28/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/27/2020

EX5G

SOU EXTENSION 5 GRANTED

02/27/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/26/2020

EXT5

SOU EXTENSION 5 FILED

02/18/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/18/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/16/2019

EX4G

SOU EXTENSION 4 GRANTED

08/14/2019

EXT4

SOU EXTENSION 4 FILED

08/14/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/14/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/13/2019

EX3G

SOU EXTENSION 3 GRANTED

02/11/2019

EXT3

SOU EXTENSION 3 FILED

02/11/2019

EEXT

SOU TEAS EXTENSION RECEIVED

02/11/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/18/2018

EX2G

SOU EXTENSION 2 GRANTED

07/16/2018

EXT2

SOU EXTENSION 2 FILED

07/16/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/16/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/09/2018

EX1G

SOU EXTENSION 1 GRANTED

02/07/2018

EXT1

SOU EXTENSION 1 FILED

02/07/2018

EEXT

SOU TEAS EXTENSION RECEIVED

02/07/2018

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/31/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/15/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/20/2017

PUBO

PUBLISHED FOR OPPOSITION

06/20/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/31/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/12/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/22/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/21/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/21/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/22/2017

GNRT

NON-FINAL ACTION E-MAILED

03/22/2017

CNRT

NON-FINAL ACTION WRITTEN

03/22/2017

DOCK

ASSIGNED TO EXAMINER

03/17/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/21/2016

NWAP

NEW APPLICATION ENTERED

12/19/2016

Continuous trademark protection

Get notified about every new filing that threatens DRUG DIFFERENTIATION BY DESIGN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.